...
首页> 外文期刊>Experimental Gerontology >Cardiac cell therapy: a realistic concept for elderly patients?
【24h】

Cardiac cell therapy: a realistic concept for elderly patients?

机译:心脏细胞疗法:老年患者的现实概念?

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Established therapeutic concepts for heart failure in elderly patients aim at long-term medical and/or surgical palliation. Heart transplantation is limited to younger individuals, and permanent mechanical assist devices are not yet widely used. In this situation, myocardial cell therapy offers fascinating new perspectives, the ultimate goal being the complete regeneration of heart muscle and blood vessel cells. In small animal models, myocardial cell therapy often leads to a striking improvement of heart function, but the success in man has so far been modest. A possible explanation for the problems with bench-to-bedside translation of cardiac cell therapy is that mainly autologous cell products from aged patients with chronic diseases have been used so far. The aim of this paper is to summarize the current state of development of clinical cardiac cell therapy, to outline how autologous regenerative cells are subject to ageing processes, and to discuss whether the cardiac cell therapy in its present form is a realistic concept for elderly patients.
机译:已建立的老年患者心力衰竭的治疗概念旨在长期内科和/或外科治疗。心脏移植仅限于年轻人,永久性机械辅助设备尚未广泛使用。在这种情况下,心肌细胞疗法提供了令人着迷的新观点,最终目标是使心肌和血管细胞完全再生。在小型动物模型中,心肌细胞疗法通常可显着改善心脏功能,但迄今为止,在人类中的成功还很有限。心脏细胞治疗从台到床转换的问题的一种可能解释是,到目前为止,主要使用了老年慢性病患者的自体细胞产物。本文的目的是概述临床心脏细胞治疗的发展现状,概述自体再生细胞如何经受衰老过程,并讨论目前形式的心脏细胞治疗是否对老年患者是现实的概念。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号